[The epiphyseal involvement of metaphyseal bone sarcomas in patients with fertile growth plates. A magnetic resonance assessment].

Reconstruction with ipsilateral fibula transfer with pasteurized bone after excision of bone sarcoma of the tibia. Sarcoma (2004) 0.79

Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med (1995) 4.11

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol (2001) 3.29

Unicameral and aneurysmal bone cysts. Clin Orthop Relat Res (1986) 2.78

Aneurysmal bone cyst of the mobile spine: report on 41 cases. Spine (Phila Pa 1976) (2001) 2.37

Pyrazolo-triazoles as light activable DNA cleaving agents. Bioorg Med Chem (2000) 2.30

Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol (1994) 2.20

Expression and localization of ATP binding cassette transporter A1 (ABCA1) in first trimester and term human placenta. Placenta (2010) 2.09

Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol (2000) 2.06

Chondroblastoma. A review of seventy cases. J Bone Joint Surg Am (1985) 1.84

Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin. J Clin Oncol (1998) 1.80

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol (2000) 1.77

Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling. Oncogene (2011) 1.67

Chondrosarcoma of the mobile spine: report on 22 cases. Spine (Phila Pa 1976) (2000) 1.67

Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target. Cancer Res (1996) 1.65

Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice. Cancer Res (1998) 1.64

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer (1993) 1.58

Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol (1997) 1.56

Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol (2003) 1.50

Possible donor-recipient bartonellosis transmission in a pediatric liver transplant. Transpl Infect Dis (2008) 1.49

Mesenchymal chondrosarcoma of bone and soft tissues. Cancer (1983) 1.48

Parosteal osteosarcoma dedifferentiating into telangiectatic osteosarcoma: importance of lytic changes and fluid cavities at imaging. Skeletal Radiol (2009) 1.47

Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am (1981) 1.46

Histologically verified lung metastases in benign giant cell tumours--14 cases from a single institution. Int Orthop (2006) 1.43

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. Ann Oncol (2011) 1.40

Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer (1989) 1.40

Hospital use of decontaminating mats. J Hosp Infect (2003) 1.39

A(3) adenosine receptor ligands: history and perspectives. Med Res Rev (2000) 1.35

Aneurysmal bone cyst of the spine. J Bone Joint Surg Am (1985) 1.34

MR of benign peripheral nerve sheath tumors. J Comput Assist Tomogr (1991) 1.34

In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. J Orthop Res (2006) 1.34

C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology (1998) 1.33

SV40-like sequences in human bone tumors. Oncogene (1996) 1.33

Giant-cell tumor of bone in skeletally immature patients. J Bone Joint Surg Am (1983) 1.31

Solid variant of aneurysmal bone cyst. Cancer (1993) 1.30

Esophageal replacement: gastric tube or whole stomach? Ann Thorac Surg (1995) 1.30

Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells. Clin Cancer Res (2001) 1.29

The healing of confined critical size cancellous defects in the presence of silk fibroin hydrogel. Biomaterials (2005) 1.28

Terminalized semimechanical side-to-side suture technique for cervical esophagogastrostomy. Ann Thorac Surg (1998) 1.27

Chondromyxoid fibroma. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am (1983) 1.26

Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. Ann Oncol (2010) 1.25

Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol (2001) 1.25

Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience. Cancer (1999) 1.24

High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study. J Chemother (2002) 1.21

Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells. Ann Oncol (2004) 1.21

Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol (1993) 1.19

Osteosarcoma. Low-grade intraosseous-type osteosarcoma, histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma. Cancer (1993) 1.18

The denervated stomach as an esophageal substitute is a contractile organ. Ann Surg (1998) 1.17

Penile Mondors' disease: an underestimated pathology. Br J Urol (1996) 1.17

High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study. J Clin Oncol (2002) 1.17

Staging of intraosseous extent of osteosarcoma: correlation of preoperative CT and MR imaging with pathologic macroslides. Radiology (1988) 1.17

Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand (1998) 1.16

Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer (1990) 1.16

Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol (1997) 1.16

Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy. Cancer (1993) 1.16

Dedifferentiated chondrosarcoma. Skeletal Radiol (1995) 1.16

Osteoid osteoma and osteoblastoma of the talus. A report of 40 cases. Skeletal Radiol (1986) 1.14

Massive bone allograft reconstruction in high-grade osteosarcoma. Clin Orthop Relat Res (2000) 1.13

Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor. Cancer (1985) 1.13

Cellular schwannoma. A clinicopathologic, DNA flow cytometric, and proliferation marker study of 70 patients. Cancer (1995) 1.12

[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. Mol Pharmacol (2000) 1.12

Osteoblastoma-like osteosarcoma. The Rizzoli Institute experience. Mod Pathol (1993) 1.12

Symptomatic vertebral hemangioma: the treatment of 23 cases and a review of the literature. Chir Organi Mov (2002) 1.11

Denervated stomach as an esophageal substitute recovers intraluminal acidity with time. Ann Surg (2001) 1.11

Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. Cancer (1997) 1.11

The management of malignant bone tumors in children and adolescents. Clin Orthop Relat Res (1991) 1.09

CD99 engagement: an effective therapeutic strategy for Ewing tumors. Cancer Res (2000) 1.08

Osteoblastoma of the spine. Clin Orthop Relat Res (1992) 1.08

Free vascularized growth-plate transfer after bone tumor resection in children. J Reconstr Microsurg (1998) 1.08

Osteosarcoma of the bones of the foot--an easily misdiagnosed malignant tumor. Mayo Clin Proc (1998) 1.08

Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone. Virchows Arch (2009) 1.07

Sarcomatous degeneration of giant cell tumours. Ital J Orthop Traumatol (1986) 1.07

Unicameral and aneurysmal bone cysts. Orthop Clin North Am (1996) 1.07

Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience. Ann Oncol (1992) 1.06

Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol Histopathol (2004) 1.05

Giant cell tumor of bone: a model for the in vitro human osteoclast characterization. Tumori (1989) 1.05

Dedifferentiated chondrosarcoma. J Bone Joint Surg Am (1988) 1.05

Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders. J Med Chem (2001) 1.04

Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor. Bioorg Med Chem Lett (2000) 1.04

Risk factors for local recurrences after limb-salvage surgery for high-grade osteosarcoma of the extremities. Ann Oncol (1997) 1.04

Surgical treatment of giant-cell tumor of the spine. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am (1983) 1.03

Fibroin hydrogels for biomedical applications: preparation, characterization and in vitro cell culture studies. J Biomater Sci Polym Ed (2004) 1.03

The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res (2002) 1.02

Radiological features of 24 periosteal chondrosarcomas. Skeletal Radiol (2001) 1.02

A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. J Clin Oncol (1986) 1.02

1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene (2011) 1.02

Pulsed electromagnetic fields reduce knee osteoarthritic lesion progression in the aged Dunkin Hartley guinea pig. J Orthop Res (2005) 1.02

Skeletonizing en bloc esophagectomy for cancer. Ann Surg (2001) 1.01

Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th study. Acta Oncol (1998) 1.01

Direct cortisone injection in eosinophilic granuloma of bone: a preliminary report on 11 patients. J Pediatr Orthop (1985) 1.01

Osteosarcoma of the pelvis. Eur J Surg Oncol (2004) 1.01

A new austenitic stainless steel with negligible nickel content: an in vitro and in vivo comparative investigation. Biomaterials (2003) 1.00

Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: in vitro osteoblast and osteoclast response. Acta Biomater (2008) 1.00

Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues. Int J Cancer (2000) 1.00